HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.

AbstractPURPOSE:
To determine if mosaic tuberous sclerosis complex (TSC) can be stratified into subtypes that correspond with prognosis and extent of disease.
METHODS:
Next-generation sequencing of skin tumor and other samples was used to identify patients with mosaic pathogenic variants in TSC1 or TSC2. Extent of disease, onset age, and family history of TSC were determined through retrospective analysis of patient records.
RESULTS:
The median number of disease findings and age at penetrance differed between mosaic patients with asymmetrically distributed facial angiofibromas (4 findings, 24 years, n = 7), mosaic patients with bilaterally symmetric facial angiofibromas (8 findings, 10 years, n = 12), and germline TSC patients (10 findings, 4 years, n = 29). Cutaneous and internal organ involvement positively correlated in mosaic (R = 0.62, p = 0.005), but not germline (R = -0.24, p = 0.24) TSC. Variant allele fraction (VAF) in the blood (range: 0-19%) positively correlated with the number of major features (R = 0.55, p = 0.028). Five had a TSC2 variant identified in the skin that was below detection in the blood. One of 12 children from a mosaic parent had TSC.
CONCLUSION:
The phenotype of mosaic TSC ranged from mild to indistinguishable from germline disease. Patients with mosaicism and asymmetric facial angiofibromas exhibited fewer findings, later onset, and lower VAF in the blood.
AuthorsAlison M Treichel, Lana Hamieh, Neera R Nathan, Magdalena E Tyburczy, Ji-An Wang, Oyetewa Oyerinde, Sorana Raiciulescu, Patricia Julien-Williams, Amanda M Jones, Vissaagan Gopalakrishnan, Joel Moss, David J Kwiatkowski, Thomas N Darling
JournalGenetics in medicine : official journal of the American College of Medical Genetics (Genet Med) Vol. 21 Issue 11 Pg. 2594-2604 (11 2019) ISSN: 1530-0366 [Electronic] United States
PMID31114024 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Tuberous Sclerosis Complex 1 Protein
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins
Topics
  • Adult
  • Female
  • High-Throughput Nucleotide Sequencing (methods)
  • Humans
  • Male
  • Middle Aged
  • Mosaicism
  • Mutation (genetics)
  • Phenotype
  • Retrospective Studies
  • Skin Neoplasms (genetics)
  • Tuberous Sclerosis (classification, genetics)
  • Tuberous Sclerosis Complex 1 Protein (genetics)
  • Tuberous Sclerosis Complex 2 Protein (genetics)
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: